Literature DB >> 23167503

Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.

Giovanni Del Poeta1, Michele Dal Bo, Maria Ilaria Del Principe, Federico Pozzo, Francesca Maria Rossi, Antonella Zucchetto, Riccardo Bomben, Massimo Degan, Silvia Rasi, Davide Rossi, Pietro Bulian, Gianluca Gaidano, Sergio Amadori, Valter Gattei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23167503     DOI： 10.1111/bjh.12128

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cells.

Authors:  F M Rossi; A Zucchetto; E Tissino; M Dal Bo; R Bomben; C Caldana; F Pozzo; G Del Poeta; D Rossi; G Gaidano; V Gattei
Journal:  Leukemia       Date:  2013-11-08       Impact factor: 11.528

Review 2.  Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

3.  NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

Authors:  F Pozzo; T Bittolo; F Arruga; P Bulian; P Macor; E Tissino; B Gizdic; F M Rossi; R Bomben; A Zucchetto; D Benedetti; M Degan; G D'Arena; A Chiarenza; F Zaja; G Pozzato; D Rossi; G Gaidano; G Del Poeta; S Deaglio; V Gattei; M Dal Bo
Journal:  Leukemia       Date:  2015-07-13       Impact factor: 11.528

Review 4.  The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Authors:  Gianluca Gaidano; Davide Rossi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  The Predominant Prognostic Significance of NOTCH1 Mutation Defined by Emulsion PCR in Chronic Lymphocytic Leukemia.

Authors:  Katarzyna Skórka; Michał Chojnacki; Marta Masternak; Agnieszka Karczmarczyk; Edyta Subocz; Ewa Wawrzyniak; Krzysztof Giannopoulos
Journal:  Cancer Manag Res       Date:  2021-05-06       Impact factor: 3.989

6.  Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia.

Authors:  Angela Minervini; Crescenzio Francesco Minervini; Luisa Anelli; Antonella Zagaria; Paola Casieri; Nicoletta Coccaro; Cosimo Cumbo; Giuseppina Tota; Luciana Impera; Paola Orsini; Claudia Brunetti; Annamaria Giordano; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2016-12-27

7.  Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers.

Authors:  Thomas Lewis; David B Corcoran; David E Thurston; Peter J Giles; Kevin Ashelford; Elisabeth J Walsby; Christopher D Fegan; Andrea G S Pepper; Khondaker Miraz Rahman; Chris Pepper
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

Review 8.  Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond.

Authors:  Federico Pozzo; Tamara Bittolo; Erika Tissino; Antonella Zucchetto; Riccardo Bomben; Laura Polcik; Svenja Dannewitz Prosseda; Tanja Nicole Hartmann; Valter Gattei
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

Review 9.  NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

Authors:  Emanuela Rosati; Stefano Baldoni; Filomena De Falco; Beatrice Del Papa; Erica Dorillo; Chiara Rompietti; Elisa Albi; Franca Falzetti; Mauro Di Ianni; Paolo Sportoletti
Journal:  Front Oncol       Date:  2018-06-27       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.